中国颅内破裂动脉瘤诊疗指南2021  

Chinese guidelines for diagnosis and treatment of ruptured intracranial aneurysm 2021

作　　者：中国医师协会神经介入专业委员会 中国颅内动脉瘤计划研究组 张鸿祺[2] 杨新健[3] 屈延 贺民[5] 段传志[6] 张彤宇 刘鹏 向思诗 冯华[7] 王天龙[7] 王坤[8] 刘海啸 郭为 李进 田蕊 郭慎全 何旭英[11] 赵兵[12] 王轩[13] 陈周青 吴建梁 麦麦提图尔荪·阿不杜拉 Chinese Federation of Interventional Clinical Neurosciences(CFITN);China Intracranial Aneurysm Project(CIAP)Study Group;Zhang Hongqi;Yang Xinjian;Qu Yan;He Min;Duan Chuanzhi(不详;Department of Neurosurgery,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;Department of Neurointerventional Radiology,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China;Department of Neurosurgery,Tangdu Hospital,Air Force Medical University,Xi′an 710038,China;Department of Neurosurgery,West China Hospital,Sichuan University,Chengdu 610000,China;Department of Neurosurgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510282,China)

机构地区：[1]不详 [2]首都医科大学宣武医院神经外科,北京100053 [3]首都医科大学附属北京天坛医院神经介入科,100070 [4]空军军医大学唐都医院神经外科,西安710038 [5]四川大学华西医院神经外科,成都610000 [6]南方医科大学珠江医院神经外科,广州510282 [7]首都医科大学宣武医院 [8]首都医科大学附属北京天坛医院 [9]空军军医大学唐都医院 [10]四川大学华西医院 [11]南方医科大学珠江医院 [12]上海交通大学医学院附属仁济医院 [13]天津市环湖医院 [14]苏州大学附属第一医院 [15]河北医科大学第二医院 [16]新疆医科大学第一附属医院

出　　处：《中国脑血管病杂志》2021年第8期546-574,共29页Chinese Journal of Cerebrovascular Diseases

基　　金：国家重点研发计划重大慢性非传染性疾病防控研究重点专项资助项目(2016YFC1300800)。

摘　　要：颅内动脉瘤是颅内动脉壁的局限性病理性扩张,存在破裂倾向。而颅内动脉瘤破裂是自发性蛛网膜下腔出血最常见的病因。蛛网膜下腔出血作为一种对中枢神经系统甚至其他系统造成严重损害的疾病,具有残死率高、临床症状复杂、自然史及转归不明确、治疗方式及效果不佳、并发症多样、随访不统一等一系列问题。自美国心脏协会/美国卒中协会动脉瘤性蛛网膜下腔出血指南发布后,我国先后发布了《中国蛛网膜下腔出血诊治指南2015》《中国蛛网膜下腔出血诊治指南2019》两版指南。破裂颅内动脉瘤(RIA)作为蛛网膜下腔出血的首要病因,其相关高质量研究及先进的诊疗技术陆续发布,而我国关于RIA的规范性诊疗仍缺乏推荐,故专家组结合文献、研究和临床经验共同撰写了本指南,旨在对RIA的病因、诊断、治疗、并发症以及随访等内容进行更新与改写。Intracranial aneurysms(IA)is a localized pathological dilation of intracranial arterial wall,which is prone to rupture.IA rupture is the most common cause of subarachnoid hemorrhage.The subarachnoid hemorrhage is a disease that severely affects the central nervous system and even other systems.It can cause a series of problems,such as high deformity and mortality rate,complex clinical manifestations,unclear natural history and outcomes,unfavorable treatment methods and effects,diverse complications,inconsistent follow-up,etc.Since the release of American Heart Association/American Stroke Association guidelines for the management of aneurysmal subarachnoid hemorrhage,China has released two versions of related guidelines:the Chinese Guidelines for Diagnosis and Treatment of Subarachnoid Hemorrhage 2015 and the Chinese Guidelines for Diagnosis and Treatment of Subarachnoid Hemorrhage 2019.As the primary cause of subarachnoid hemorrhage,ruptured intracranial aneurysms(RIA)related high-quality researches and advanced techniques for the management have been continuously published.However,recommendations for the diagnosis and treatment of RIA in China are still lacking.As a result,the expert group co-authors this guideline to update and rewrite the etiology,diagnosis,treatment,complications,follow-up and other contents of RIA.

关 键 词：颅内动脉瘤 破裂颅内动脉瘤 诊断 治疗 并发症 随访 指南 

分 类 号：R65[医药卫生—外科学]